These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cytochrome P450 enzymes involved in the enhancement of propranolol N-desisopropylation after repeated administration of propranolol in rats. Narimatsu S, Mochida M, Matsumoto T, Masubuchi Y, Horie T, Nagata K, Funae Y, Cho AK, Suzuki T. Chem Biol Interact; 1996 Sep 06; 101(3):207-24. PubMed ID: 8870689 [Abstract] [Full Text] [Related]
3. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes. Suzuki T, Fujita S, Narimatsu S, Masubuchi Y, Tachibana M, Ohta S, Hirobe M. FASEB J; 1992 Jan 06; 6(2):771-6. PubMed ID: 1537468 [Abstract] [Full Text] [Related]
4. Enzymatic basis for the non-linearity of hepatic elimination of propranolol in the isolated perfused rat liver. Ishida R, Suzuki K, Masubuchi Y, Narimatsu S, Fujita S, Suzuki T. Biochem Pharmacol; 1992 Dec 15; 44(12):2281-8. PubMed ID: 1472093 [Abstract] [Full Text] [Related]
5. Induction of hepatic microsomal propranolol N-desisopropylase activity by 3-methylcholanthrene and Sudan III. Fujita S, Usui T, Suzuki M, Hirasawa M, Mori Y, Naganuma H, Suzuki T. Biochem Biophys Res Commun; 1982 Apr 14; 105(3):1233-9. PubMed ID: 7092896 [No Abstract] [Full Text] [Related]
6. The effect of Sudan III on drug metabolizing enzymes. Fujita S, Peisach J, Ohkawa H, Yoshida Y, Adachi S, Uesugi T, Suzuki M, Suzuki T. Chem Biol Interact; 1984 Feb 14; 48(2):129-43. PubMed ID: 6421495 [Abstract] [Full Text] [Related]
7. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes. Masubuchi Y, Kagimoto N, Narimatsu S, Fujita S, Suzuki T. Drug Metab Dispos; 1993 Feb 14; 21(6):1012-6. PubMed ID: 7905378 [Abstract] [Full Text] [Related]
9. Role of specific cytochrome P-450 isoenzymes in the regio-selective metabolism of 7,12-dimethylbenz[a]anthracene in microsomes from rats treated with phenobarbital or Sudan III. McCord A, Burnett AK, Wolf CR, Morrison V, Craft JA. Carcinogenesis; 1988 Aug 14; 9(8):1485-91. PubMed ID: 3135957 [Abstract] [Full Text] [Related]
10. Effect of 3-methylcholanthrene on bunitrolol metabolism. Kinetics and immunological studies on 4-hydroxylation of bunitrolol catalyzed by two species of cytochromes P450 in rat liver microsomes. Fujita S, Masuda M, Shimamoto Y, Hoshi H, Kariya S, Kazusaka A, Suzuki T. Drug Metab Dispos; 1996 Feb 14; 24(2):254-9. PubMed ID: 8742239 [Abstract] [Full Text] [Related]
11. Evaluation of loratadine as an inducer of liver microsomal cytochrome P450 in rats and mice. Parkinson A, Clement RP, Casciano CN, Cayen MN. Biochem Pharmacol; 1992 May 28; 43(10):2169-80. PubMed ID: 1534660 [Abstract] [Full Text] [Related]
12. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes. Menicagli S, Lippi A, Criscuoli M, Gervasi PG. Biochem Pharmacol; 1993 Mar 09; 45(5):1097-105. PubMed ID: 8461039 [Abstract] [Full Text] [Related]
13. Induction of cytochrome P450 isozymes in rat liver by methyl n-alkyl ketones and n-alkylbenzenes. Effects of hydrophobicity of inducers on inducibility of cytochrome P450. Imaoka S, Funae Y. Biochem Pharmacol; 1991 Dec 11; 42 Suppl():S143-50. PubMed ID: 1768271 [Abstract] [Full Text] [Related]
14. Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities. Wortelboer HM, de Kruif CA, van Iersel AA, Falke HE, Noordhoek J, Blaauboer BJ. Biochem Pharmacol; 1991 Jul 05; 42(2):381-90. PubMed ID: 1859452 [Abstract] [Full Text] [Related]
15. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds. Dirven HA, van den Broek PH, Peters JG, Noordhoek J, Jongeneelen FJ. Biochem Pharmacol; 1992 Jun 23; 43(12):2621-9. PubMed ID: 1632818 [Abstract] [Full Text] [Related]
16. Paradoxical effect of Sudan III on the in vivo and in vitro genotoxicity elicited by 7,12-dimethylbenz(a)anthracene. Hatakeyama S, Hayasaki Y, Masuda M, Kazusaka A, Fujita S. J Biochem Toxicol; 1995 Jun 23; 10(3):143-9. PubMed ID: 7473605 [Abstract] [Full Text] [Related]
17. Induction of CYP2B1 and 3A1, and associated monoxygenase activities by tamoxifen and certain analogues in the livers of female rats and mice. White IN, Davies A, Smith LL, Dawson S, De Matteis F. Biochem Pharmacol; 1993 Jan 07; 45(1):21-30. PubMed ID: 8424814 [Abstract] [Full Text] [Related]
18. Kinetic analysis of propranolol-induced impairment of its own metabolism in rats. Kagimoto N, Masubuchi Y, Fujita S, Narimatsu S, Suzuki T. J Pharm Pharmacol; 1994 Jun 07; 46(6):528-30. PubMed ID: 7932057 [Abstract] [Full Text] [Related]
19. The role of specific cytochromes P450 in the formation of 7,12-dimethylbenz(a)anthracene-protein adducts in rat liver microsomes in vitro. Lambard SE, Burnett AK, Wolf CR, Craft JA. Biochem Pharmacol; 1991 Sep 27; 42(8):1529-35. PubMed ID: 1930280 [Abstract] [Full Text] [Related]
20. Alterations in the metabolism of 7,12-dimethylbenz[a]anthracene and various xenobiotics by rat hepatic microsomes following Sudan III treatment in vivo. O'Dowd JJ, Burnett AK, Weston A, Bulleid NJ, Craft JA. Carcinogenesis; 1985 Mar 27; 6(3):469-72. PubMed ID: 3919957 [Abstract] [Full Text] [Related] Page: [Next] [New Search]